1. Home
  2. FSK vs LNTH Comparison

FSK vs LNTH Comparison

Compare FSK & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS KKR Capital Corp.

FSK

FS KKR Capital Corp.

HOLD

Current Price

$14.67

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$66.17

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSK
LNTH
Founded
2007
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FSK
LNTH
Price
$14.67
$66.17
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$17.33
$78.00
AVG Volume (30 Days)
2.9M
1.2M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
19.06%
N/A
EPS Growth
N/A
N/A
EPS
0.97
2.39
Revenue
$1,578,000,000.00
$1,525,933,000.00
Revenue This Year
N/A
$0.01
Revenue Next Year
N/A
$1.24
P/E Ratio
$15.13
$27.55
Revenue Growth
N/A
1.95
52 Week Low
$14.05
$47.25
52 Week High
$24.10
$111.29

Technical Indicators

Market Signals
Indicator
FSK
LNTH
Relative Strength Index (RSI) 32.76 67.34
Support Level $15.03 $64.13
Resistance Level $15.37 $67.01
Average True Range (ATR) 0.31 2.17
MACD -0.11 0.32
Stochastic Oscillator 0.79 84.68

Price Performance

Historical Comparison
FSK
LNTH

About FSK FS KKR Capital Corp.

FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: